In glucose-intolerant Goto-Kakizaki rats, treatment with GLP-1 increased both the pancreatic insulin content and -cell mass [36]
Glucagon-like peptide 1 receptor (GLP-1R) expression by nerve fibres in inflammatory bowel disease and functional effects in cultured neurons
Research compound for metabolic studies
According to FDA prescribing information, gastroesophageal reflux disease appears among common adverse reactions for Zepbound, while dyspepsia is noted for Mounjaro
Every time you insert a needle into a vial, there is a tiny risk of introducing air or contaminants, which can affect how long the medication stays stable
Common GLP-1 medications available in the UK include: GLP-1 receptor agonists: Semaglutide (Ozempic for diabetes, Wegovy for weight management) Liraglutide (Victoza for diabetes, Saxenda for weight management) Dulaglutide (Trulicity for diabetes) Dual GIP/GLP-1 receptor agonist: Tirzepatide (Mounjaro for diabetes, Zepbound for weight management) These medications are administered via subcutaneous injection, typically weekly or daily depending on the specific formulation